Survivin: A molecular biomarker in cancer
Survivin, a member of the inhibitor of apoptosis (IAP) protein family that inhibits caspases and blocks cell death, is highly expressed in most cancers and is associated with a poor clinical outcome. Survivin has consistently been identified by molecular profiling analysis to be associated with high...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Series: | Indian Journal of Medical Research |
| Subjects: | |
| Online Access: | http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2015;volume=141;issue=4;spage=389;epage=397;aulast=Jaiswal |
| _version_ | 1798043919004467200 |
|---|---|
| author | Praveen Kumar Jaiswal Apul Goel R D Mittal |
| author_facet | Praveen Kumar Jaiswal Apul Goel R D Mittal |
| author_sort | Praveen Kumar Jaiswal |
| collection | DOAJ |
| description | Survivin, a member of the inhibitor of apoptosis (IAP) protein family that inhibits caspases and blocks cell death, is highly expressed in most cancers and is associated with a poor clinical outcome. Survivin has consistently been identified by molecular profiling analysis to be associated with high tumour grade cancers, different disease survival and recurrence. Polymorphisms in the survivin gene are emerging as powerful tools to study the biology of the disease and have the potential to be used in disease prognosis and diagnosis. The survivin gene polymorphisms have also been reported to influence tumour aggressiveness as well as survival of cancer patients. The differential expression of survivin in cancer cells compared to normal tissues and its role as a nodal protein in a number of cellular pathways make it a high target for different therapeutics. This review discusses the complex circuitry of survivin in human cancers and gene variants of survivin, and highlights novel therapy that targets this important protein. |
| first_indexed | 2024-04-11T22:55:43Z |
| format | Article |
| id | doaj.art-ba67d0405d2c4f61bf05646a362773c1 |
| institution | Directory Open Access Journal |
| issn | 0971-5916 |
| language | English |
| last_indexed | 2024-04-11T22:55:43Z |
| publishDate | 2015-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Medical Research |
| spelling | doaj.art-ba67d0405d2c4f61bf05646a362773c12022-12-22T03:58:27ZengWolters Kluwer Medknow PublicationsIndian Journal of Medical Research0971-59162015-01-01141438939710.4103/0971-5916.159250Survivin: A molecular biomarker in cancerPraveen Kumar JaiswalApul GoelR D MittalSurvivin, a member of the inhibitor of apoptosis (IAP) protein family that inhibits caspases and blocks cell death, is highly expressed in most cancers and is associated with a poor clinical outcome. Survivin has consistently been identified by molecular profiling analysis to be associated with high tumour grade cancers, different disease survival and recurrence. Polymorphisms in the survivin gene are emerging as powerful tools to study the biology of the disease and have the potential to be used in disease prognosis and diagnosis. The survivin gene polymorphisms have also been reported to influence tumour aggressiveness as well as survival of cancer patients. The differential expression of survivin in cancer cells compared to normal tissues and its role as a nodal protein in a number of cellular pathways make it a high target for different therapeutics. This review discusses the complex circuitry of survivin in human cancers and gene variants of survivin, and highlights novel therapy that targets this important protein.http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2015;volume=141;issue=4;spage=389;epage=397;aulast=JaiswalCancer - cancer therapy - gene polymorphism - surviving |
| spellingShingle | Praveen Kumar Jaiswal Apul Goel R D Mittal Survivin: A molecular biomarker in cancer Indian Journal of Medical Research Cancer - cancer therapy - gene polymorphism - surviving |
| title | Survivin: A molecular biomarker in cancer |
| title_full | Survivin: A molecular biomarker in cancer |
| title_fullStr | Survivin: A molecular biomarker in cancer |
| title_full_unstemmed | Survivin: A molecular biomarker in cancer |
| title_short | Survivin: A molecular biomarker in cancer |
| title_sort | survivin a molecular biomarker in cancer |
| topic | Cancer - cancer therapy - gene polymorphism - surviving |
| url | http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2015;volume=141;issue=4;spage=389;epage=397;aulast=Jaiswal |
| work_keys_str_mv | AT praveenkumarjaiswal survivinamolecularbiomarkerincancer AT apulgoel survivinamolecularbiomarkerincancer AT rdmittal survivinamolecularbiomarkerincancer |